KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Aquestive Therapeutics (AQST) EBT Margin: 2017-2024

Historic EBT Margin for Aquestive Therapeutics (AQST) over the last 8 years, with Dec 2024 value amounting to -4,380.06%.

  • Aquestive Therapeutics' EBT Margin fell 3562.00% to -120.61% in Q3 2025 from the same period last year, while for Sep 2025 it was 524.42%, marking a year-over-year increase of 58400.00%. This contributed to the annual value of -4,380.06% for FY2024, which is 436499.00% down from last year.
  • Per Aquestive Therapeutics' latest filing, its EBT Margin stood at -4,380.06% for FY2024, which was down 28,956.60% from -15.07% recorded in FY2023.
  • Over the past 5 years, Aquestive Therapeutics' EBT Margin peaked at -15.07% during FY2023, and registered a low of -4,380.06% during FY2024.
  • Over the past 3 years, Aquestive Therapeutics' median EBT Margin value was -114.11% (recorded in 2022), while the average stood at -1,503.08%.
  • Per our database at Business Quant, Aquestive Therapeutics' EBT Margin skyrocketed by 125,581bps in 2021 and then crashed by 436,499bps in 2024.
  • Over the past 5 years, Aquestive Therapeutics' EBT Margin (Yearly) stood at -1,394.58% in 2020, then surged by 125,581bps to -138.77% in 2021, then skyrocketed by 2,465bps to -114.11% in 2022, then soared by 9,904bps to -15.07% in 2023, then tumbled by 436,499bps to -4,380.06% in 2024.